Werkgroep Cardiologische centra Nederland
Menu

TRA-CER (Completed)

Trial to Assess the Effects of SCH 530348 in Preventing Heart Attack and Stroke in Patients With Acute Coronary Syndrome (TRA•CER)
Medicine
SCH 530348
Population
ASCVD
Phase
III
Starting year
2008
More information
ClinicalTrials.gov

Publications: TRA-CER

  • Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.J Am Coll Cardiol - Abstract - Cornel, prof. dr. J.H. - TRA-CER - ASCVD
  • Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).Am J Cardiol - Abstract - Cornel, prof. dr. J.H. - TRA-CER - ASCVD
  • Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy.Thromb Haemost - Abstract - Cornel, prof. dr. J.H. - TRA-CER - ASCVD

Publications by WCN study

Publications WCN studies by WCN member